Welcome to our dedicated page for Mirion Technologies news (Ticker: MIR), a resource for investors and traders seeking the latest updates and insights on Mirion Technologies stock.
Mirion Technologies, Inc. (NYSE: MIR) is a global provider of radiation detection, measurement, analysis, and monitoring solutions serving nuclear, medical, defense, and research end markets. This news page aggregates company press releases and third-party coverage so readers can follow how Mirion’s activities in radiation safety, science, and medicine develop over time.
Recent Mirion news has highlighted its role in the nuclear power sector and capital markets. The company announced a definitive agreement to acquire, and later the completion of the acquisition of, Paragon Energy Solutions, a provider of highly engineered solutions for large-scale nuclear power plants and small modular reactors in the United States. News releases describe how Paragon’s systems and solutions are present in all nuclear reactors in North America and how the acquisition is intended to broaden Mirion’s portfolio for nuclear power customers, including SMRs, within the Mirion Nuclear & Safety group.
Investors and observers can also find updates on Mirion’s financial performance and financing activities. The company issues quarterly earnings press releases, such as its announcement of third quarter 2025 results, and provides guidance commentary. Additional news covers public offerings of Class A common stock, convertible senior notes offerings, and related financing steps to support acquisitions and general corporate purposes.
Beyond transactions and earnings, Mirion’s news flow includes strategic collaborations. A notable example is its partnership agreement and practical arrangements with the International Atomic Energy Agency (IAEA) to cooperate in radiation detection and measurement, including support for the IAEA’s Terrestrial Environmental Radiochemistry Laboratory. For ongoing insight into MIR stock-related developments, nuclear and medical segment updates, and regulatory or partnership announcements, readers can review this news feed regularly.
Mirion Technologies (NYSE:MIR) has announced a definitive agreement to acquire Computerized Imaging Reference Systems, Inc. (CIRS) for approximately $54 million. CIRS, based in Norfolk, Virginia, specializes in developing medical imaging and radiation therapy phantoms, projecting Adjusted Revenue of $16 million and Adjusted EBITDA of $5 million for 2022. The acquisition is expected to enhance Mirion's medical segment and improve margins through operational synergies, making it accretive to adjusted EBITDA margins after integration costs. The transaction is slated to close in Q4 2021.
Mirion Technologies (NYSE: MIR) will announce its financial results for the quarter ending
Mirion Technologies, Inc. (NYSE:MIR) has acquired CHP Dosimetry, a U.S.-based dosimetry services distributor, effective November 1, 2021. CHP Dosimetry, founded in 2004 and located in Clinton, TN, generated $1.2 million in revenue in 2020. This acquisition allows Mirion to serve existing CHP customers directly and leverage CHP's distribution channels for its dosimetry solutions, including the Instadose® platform, improving service efficiency and customer reach.
Mirion Technologies (NYSE: MIR) has commenced trading on the New York Stock Exchange following its successful business combination with GS Acquisition Holdings Corp II. The company's Class A common stock and warrants are now trading under the symbols 'MIR' and 'MIRW'. With a fiscal year 2021 revenue of $612 million, reflecting a growth of 27.9% year-over-year, Mirion aims to expand its product offerings in industrial technology and medical sectors. CEO Thomas Logan anticipates continued growth and welcomes Larry Kingsley as Chairman to lead strategic initiatives.